Correlation Between Haemonetics and Cooper Companies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Haemonetics and Cooper Companies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haemonetics and Cooper Companies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haemonetics and The Cooper Companies, you can compare the effects of market volatilities on Haemonetics and Cooper Companies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haemonetics with a short position of Cooper Companies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haemonetics and Cooper Companies.

Diversification Opportunities for Haemonetics and Cooper Companies

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Haemonetics and Cooper is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Haemonetics and The Cooper Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cooper Companies and Haemonetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haemonetics are associated (or correlated) with Cooper Companies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cooper Companies has no effect on the direction of Haemonetics i.e., Haemonetics and Cooper Companies go up and down completely randomly.

Pair Corralation between Haemonetics and Cooper Companies

Considering the 90-day investment horizon Haemonetics is expected to generate 1.15 times more return on investment than Cooper Companies. However, Haemonetics is 1.15 times more volatile than The Cooper Companies. It trades about 0.18 of its potential returns per unit of risk. The Cooper Companies is currently generating about -0.5 per unit of risk. If you would invest  7,982  in Haemonetics on January 20, 2024 and sell it today you would earn a total of  364.00  from holding Haemonetics or generate 4.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Haemonetics  vs.  The Cooper Companies

 Performance 
       Timeline  
Haemonetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Haemonetics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cooper Companies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Cooper Companies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Cooper Companies is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Haemonetics and Cooper Companies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Haemonetics and Cooper Companies

The main advantage of trading using opposite Haemonetics and Cooper Companies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haemonetics position performs unexpectedly, Cooper Companies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies will offset losses from the drop in Cooper Companies' long position.
The idea behind Haemonetics and The Cooper Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data